Journey Medical has claimed FDA approval for its Emrosi therapy for rosacea, which it thinks could become a "standard of care" drug for the common skin disorder. The new capsule formulation of the ...
3mon
Medpage Today on MSNFDA Approves New Option for RosaceaThe FDA approved minocycline hydrochloride extended-release capsules (Emrosi) for treating inflammatory lesions of rosacea in ...
The approval Journey Medical received from FDA for Emrosi makes DERM an exciting stock. Click here to read more.
Journey Medical's future hinges on Emrosi, a new formulation of minocycline for rosacea, showing superior efficacy. Read why ...
Dr. Jacqueline Corrigan-Curay, acting director of the FDA's Center for Drug Evaluation and Research, said in a news release that the drug's approval “offers an opportunity to mitigate certain ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results